Correction:SARS-CoV-2-specific immune response in COYID-19 convalescent individuals
摘要
After online publication of the article1 the authors noticed an error in the figure legends of Fig.1 and Supplementary Materials Fig.S2,where the"*P<0.05,0.05<**P<0.001,***P<0.001W.should be replaced by n*P<0.05,**P<0.01,***P<0.001M.The original article has been corrected.
参考文献1
-
1Yunbao Pan,Xianghu Jiang,Liu Yang,Liangjun Chen,Xiaojiao Zeng,Guohong Liu,Yueting Tang,Chungen Qian,Xinming Wang,Fangming Cheng,Jun Lin,Xinghuan Wang,Yirong Li.SARS-CoV-2-specific immune response in COVID-19 convalescent individuals[J].Signal Transduction and Targeted Therapy,2021,6(8):2484-2493. 被引量：2
二级参考文献4
-
1吕新军(编译),Huang C,Wang Y,Li X.武汉市新型冠状病毒感染患者的临床特征[J].中华实验和临床病毒学杂志,2020,34(1):42-42. 被引量：2547
-
2Yonggang Zhou,Binqing Fu,Xiaohu Zheng,Dongsheng Wang,Changcheng Zhao,Yingjie Qi,Rui Sun,Zhigang Tian,Xiaoling Xu,Haiming Wei.Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients[J].National Science Review,2020,7(6):998-1002. 被引量：67
-
3Hong-Yi Zheng,Mi Zhang,Cui-Xian Yang,Nian Zhang,Xi-Cheng Wang,Xin-Ping Yang,Xing-Qi Dong,Yong-Tang Zheng.Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients[J].Cellular & Molecular Immunology,2020,17(5):541-543. 被引量：51
-
4Li Tan,Qi Wang,Duanyang Zhang,Jinya Ding,Qianchuan Huang,Yi-Quan Tang,Qiongshu Wang,Hongming Miao.Lymphopenia predicts disease severity of COVID-19:a descriptive and predictive study[J].Signal Transduction and Targeted Therapy,2020,5(1):2129-2131. 被引量：35
-
1Chunyu Li,Ming Niu,Zhaofang Bai,Congen Zhang,Yanling Zhao,Ruiyu Li,Can Tu,Huifang Li,Jing Jing,Yakun Meng,Zhijie Ma,Wuwen Feng,Jinfa Tang,Yun Zhu,Jinjie Li,Xiaoya Shang,Zhengsheng Zou,Xiaohe Xiao,Jiabo Wang.Screening for main components associated with the idiosyncratic hepatotoxicity of a tonic herb,Polygonum multiflorum[J].Frontiers of Medicine,2021,15(2):330-332.
-
2ChangDong Lin,Yue Li,YueBin Zhang,ZhaoYuan Liu,Xia Mu,Chenjian Gu,Jing Liu,Yutang Li,GuoHui Li,JianFeng Chen.Correction To:Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction[J].Signal Transduction and Targeted Therapy,2021,6(7):2251-2251. 被引量：1
-
3Information for Authors[J].Journal of Traditional Chinese Medicine,2021,41(4):658-660.
